- Home
- TRT vs IGC Comparison
TRT vs IGC Comparison
Compare TRT & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- IGC
- Stock Information
- Founded
- TRT 1958
- IGC 2005
- Country
- TRT United States
- IGC United States
- Employees
- TRT N/A
- IGC N/A
- Industry
- TRT Industrial Machinery/Components
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- IGC Health Care
- Exchange
- TRT Nasdaq
- IGC Nasdaq
- Market Cap
- TRT 22.2M
- IGC 20.2M
- IPO Year
- TRT N/A
- IGC N/A
- Fundamental
- Price
- TRT $5.13
- IGC $0.31
- Analyst Decision
- TRT
- IGC Strong Buy
- Analyst Count
- TRT 0
- IGC 2
- Target Price
- TRT N/A
- IGC $3.88
- AVG Volume (30 Days)
- TRT 5.3K
- IGC 213.7K
- Earning Date
- TRT 05-13-2025
- IGC 06-23-2025
- Dividend Yield
- TRT N/A
- IGC N/A
- EPS Growth
- TRT N/A
- IGC N/A
- EPS
- TRT 0.00
- IGC N/A
- Revenue
- TRT $35,548,000.00
- IGC $1,236,000.00
- Revenue This Year
- TRT N/A
- IGC N/A
- Revenue Next Year
- TRT N/A
- IGC $16.45
- P/E Ratio
- TRT $1,155.38
- IGC N/A
- Revenue Growth
- TRT N/A
- IGC 1.65
- 52 Week Low
- TRT $4.62
- IGC $0.25
- 52 Week High
- TRT $7.88
- IGC $0.55
- Technical
- Relative Strength Index (RSI)
- TRT 49.23
- IGC 48.79
- Support Level
- TRT $4.85
- IGC $0.30
- Resistance Level
- TRT $5.36
- IGC $0.33
- Average True Range (ATR)
- TRT 0.20
- IGC 0.02
- MACD
- TRT 0.02
- IGC -0.00
- Stochastic Oscillator
- TRT 68.92
- IGC 13.20
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.